Skip to content
Screener

Evolus EOLS Gross margin

Gross margin at other companies

AbbVie logo
AbbVieABBV
71.5%+0.5pp

Other financials

Income statement

See full
Revenue$84.1M+21.2%
Gross profit$57.2M+26.2%
Operating income-$4.5M+55.5%
Net income-$8.1M+53.0%
EPS (diluted)-$0.12+55.6%

Balance sheet

See full
Cash & equivalents$45.2M-26.8%
Total debt$164.8M+12.3%
Total equity-$30.9M-65.7%
Total assets$248.0M+8.4%

Cash flow

See full
Operating cash flow-$3.6M+85.5%
CapEx$50.0K-92.7%
Free cash flow-$3.6M+85.7%

Valuation

See full
Market cap$501.32M+31.4%
Enterprise value$620.96M+33.1%
P/S1.6×+0.2×

Profitability

See full
Operating margin-13.7%-1.9pp
Net margin-10.9%-3.7pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio1.7×-0.6×

Where this comes from

Calculated from Evolus’s reported figures.

Based on trailing twelve months.

The source filing: Evolus’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053468

FAQ

What is Evolus's gross margin?
Evolus (EOLS) reported gross margin of 66.7% in Q2 2026.
How has Evolus's gross margin changed year-over-year?
Evolus's gross margin decreased by 0.7% year-over-year, from 67.2% to 66.7%.
What is the long-term trend for Evolus's gross margin?
Over 5 years (2020 to 2025), Evolus's gross margin has grown at a -0.4% compound annual growth rate (CAGR), from 67.6% to 66.3%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.

Ask your AI about Evolus's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude